Figure 6. Patients with higher ARGRS were resistance to immunotherapy. (A) The correlation among 29 immune cell types and immune-related pathways and ARGRS in the GSE126044 cohort. (B) Left: Correlation between ARGRS and ImmuneScore in the GSE126044 cohort. Right: Boxplot showing the levels of ImmuneScore between ARGRS-high and low groups. (C) Left: Correlation between ARGRS and TumorPurity in the GSE126044 cohort. Right: Boxplot showing the levels of TumorPurity between ARGRS-high and low groups. (D) Barplot showing the percentage of immunotherapy responsive and non-responsive NSCLC patients in ARGRS-high and low groups. (E) The correlation among 29 immune cell types and immune-related pathways and ARGRS in the GSE135222 cohort. (F) Left: Correlation between ARGRS and ImmuneScore in the GSE135222 cohort. Right: Boxplot showing the levels of ImmuneScore between ARGRS-high and low groups. (G) Left: Correlation between ARGRS and TumorPurity in the GSE135222 cohort. Right: Boxplot showing the levels of TumorPurity between ARGRS-high and low groups. (H) Survival analysis showing the prognostic value of ARGRS in the GSE135222 cohort.